Erick DeVinney - Dec 15, 2021 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
VP Peripheral Nerve Science
Signature
/s/Erick DeVinney
Stock symbol
AXGN
Transactions as of
Dec 15, 2021
Transactions value $
-$5
Form type
4
Date filed
12/17/2021, 03:02 PM
Previous filing
Jul 21, 2021
Next filing
Dec 22, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXGN Common Stock Options Exercise $36.7K +10K +12.43% $3.67 90.4K Dec 15, 2021 Direct F1
transaction AXGN Common Stock Tax liability -$36.7K -4.17K -4.61% $8.80 86.3K Dec 15, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Employee Stock Option (right to buy) Options Exercise $0 -10K -100% $0.00* 0 Dec 15, 2021 Common Stock 10K $3.67 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This reflects the number of shares that became vested as of December 29, 2018.
F2 Represents the number of shares swapped to cover the exercise price of the options exercised via an attestation method stock swap in accordance with Rule16b-3.